Structural and functional changes in peripheral vasculature of Fabry patients

Journal of Inherited Metabolic Disease

Volumn 29, Issue 5, 2006, Pages 660-666

  Kalliokoski, Riikka J ^a   Kalliokoski, Kari K ^a   Penttinen, Maila ^a   Kantola, Ilkka ^a   Leino, Aila ^b,c   Viikari, Jorma S ^a   Simell, Olli ^a   Nuutila, Pirjo ^a   Raitakari, Olli T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL AORTA; ADULT; AGE DISTRIBUTION; ARTERY COMPLIANCE; ARTERY DILATATION; ARTERY DISEASE; ARTERY INTIMA; ARTICLE; BLOOD VESSEL WALL; BRACHIAL ARTERY; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FABRY DISEASE; FEMALE; HUMAN; MALE; PERIPHERAL CIRCULATION; SMOKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALPHA-GALACTOSIDASE; CASE-CONTROL STUDIES; CERAMIDES; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FABRY DISEASE; FEMALE; GLYCOSPHINGOLIPIDS; HUMANS; INFANT; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; TUNICA INTIMA; TUNICA MEDIA;

EID: 33748712030     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-006-0340-x     Document Type: Article

References (48)

1. Aggoun Y, Bonnet D, Sidi D, et al (2000) Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 20: 2070-2075.
2. Åkerblom HK, Viikari J, Uhari M, et al (1985) Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand Suppl 318: 49-63.
3. Altarescu G, Moore DF, Pursley R, et al (2001) Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 32: 1559-1562.
4. Bodary PF, Shen Y, Vargas FB, et al (2005) Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency. Circulation 111: 629-632.
5. Borow KM, Newburger JW (1982) Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: Comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. Am Heart J 103: 879-886.
6. Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP (2001) Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 38: 629-631.
7. Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP (2002) Arterial remodelling in Fabry disease. Acta Paediatr Suppl 91: 62-66.
8. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 276: 1163-1167.
9. Buus NH, Bottcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ (2001) Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104: 2305-2310.
10. Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH (1976) Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 54: 818-825.
11. Elleder M (2003) Sequelae of storage in Fabry disease-pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl 92: 46-53.
12. Elliott PM, Kindler H, Shah JS, et al (2006) Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart 92: 357-360.
13. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
14. Hu FB, Hedeker D, Flay BR, Sussman S, Day LE, Siddiqui O (1996) The patterns and predictors of smokeless tobacco onset among urban public school teenagers. Am J Prev Med 12: 22-28.
15. Jartti L, Ronnemaa T, Kaprio J, et al (2002) Population-based twin study of the effects of migration from Finland to Sweden on endothelial function and intima-media thickness. Arterioscler Thromb Vasc Biol 22: 832-837.
16. Järvisalo MJ, Jartti L, Toikka JO, Hartiala JJ, Ronnemaa T, Raitakari OT (2000) Noninvasive assessment of brachial artery endothelial function with digital ultrasound and 13-MHz scanning frequency: Feasibility of measuring the true inner luminal diameter using the intima-lumen interface. Ultrasound Med Biol 26: 1257-1260.
17. Järvisalo MJ, Jartti L, Nanto-Salonen K, et al (2001) Increased aortic intima-media thickness: A marker of preclinical atherosclerosis in high-risk children. Circulation 104: 2943-2947.
18. Järvisalo MJ, Raitakari M, Toikka JO, et al (2004) Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 109: 1750-1755.
19. Joannides R, Haefeli WE, Linder L, et al (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91: 1314-1319.
20. Juonala M, Jarvisalo MJ, Maki-Torkko N, Kahonen M, Viikari JS, Raitakari OT (2005a) Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation 112: 1486-1493.
21. Juonala M, Viikari JS, Kahonen M, et al (2005b) Geographic origin as a determinant of carotid artery intima-media thickness and brachial artery flow-mediated dilation: The Cardiovascular Risk in Young Finns study. Arterioscler Thromb Vasc Biol 25: 392-398.
22. Kalliokoski RJ, Kalliokoski KK, Sundell J, et al (2005) Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease. J Inherit Metab Dis 28: 563-573.
23. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP (1993) An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 14: 160-167.
24. Kostner GM (1976) Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation [Letter]. Clin Chem 22: 695.
25. Laurent S (1995) Arterial wall hypertrophy and stiffness in essential hypertensive patients. Hypertension 26: 355-362.
26. Lehmann ED, Gosling RG, Sonksen PH (1992a) Arterial wall compliance in diabetes. Diabet Med 9: 114-119.
27. Lehmann ED, Watts GF, Fatemi-Langroudi B, Gosling RG (1992b) Aortic compliance in young patients with heterozygous familial hypercholesterolaemia. Clin Sci (Lond) 83: 717-721.
28. Linhart A, Lubanda JC, Palecek T, et al (2001) Cardiac manifestations in Fabry disease. J Inherit Metab Dis 24 (Suppl 2): 75-83.
29. MacDermot KD, Holmes A, Miners AH (2001a) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38: 769-775.
30. MacDermot KD, Holmes A, Miners AH (2001b) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38: 750-760.
31. McGill HC, Jr., McMahan CA, Herderick EE, et al (2000) Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 20: 836-845.
32. Moller AT, Feldt-Rasmussen U, Rasmussen AK, et al (2006) Small-fibre neuropathy in female Fabry patients: Reduced allodynia and skin blood flow after topical capsaicin. J Peripher Nerv Syst 11: 119-125.
33. Moore DF, Herscovitch P, Schiffmann R (2001a) Selective arterial distribution of cerebral hyperperfusion in Fabry disease. J Neuroimaging 11: 303-307.
34. Moore DF, Scott LT, Gladwin MT, et al (2001b) Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 104: 1506-1512.
35. Moore DF, Altarescu G, Ling GS, et al (2002a) Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 33: 525-531.
36. Moore DF, Altarescu G, Pursley R, et al (2002b) Arterial wall properties and Womersley flow in Fabry disease. BMC Cardiovasc Disord 2: 1.
37. Mullen MJ, Kharbanda RK, Cross J, et al (2001) Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: Relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 88: 145-151.
38. Nagai Y, Fleg JL, Kemper MK, Rywik TM, Earley CJ, Metter EJ (1999) Carotid arterial stiffness as a surrogate for aortic stiffness: relationship between carotid artery pressure-strain elastic modulus and aortic pulse wave velocity. Ultrasound Med Biol 25: 181-188.
39. Pannier BM, Cambillau MS, Vellaud V, Atger V, Moatti N, Safar ME (1994a) Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. Clin Invest Med 17: 42-51.
40. Pannier BM, Lafleche AB, Girerd XJ, London GM, Safar ME (1994b) Arterial stiffness and wave reflections following acute calcium blockade in essential hypertension. Am J Hypertens 7: 168-176.
41. Pfeilschifter J, Huwiler A (2000) Ceramides as key players in cellular stress response. News Physiol Sci 15: 11-15.
42. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR (1995) Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91: 1432-1443.
43. Schiffmann R, Rapkiewicz A, Abu-Asab M, et al (2005) Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch 29: 1-7.
44. Seino Y, Vyden JK, Philippart M, Rose HB, Nagasawa K (1983) Peripheral hemodynamics in patients with Fabry's disease. Am Heart J 105: 783-787.
45. Stemper B, Hilz MJ (2003) Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease. J Neurol 250: 970-976.
46. Toikka JO, Niemi P, Ahotupa M, et al (1999) Large-artery elastic properties in young men: Relationships to serum lipoproteins and oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 19: 436-441.
47. Tounian P, Aggoun Y, Dubern B, et al (2001) Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study. Lancet 358: 1400-1404.
48. Vance DE, Krivit W, Sweeley CC (1975) Metabolism of neutral glycosphingolipids in plasma of a normal human and a patient with Fabry's disease. J Biol Chem 250: 8119-8125.